This inventor holds 1 USPTO granted patent. Top assignee: Vela Acquisition Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Mallikarjun Reddy Ravi
Introduction
Mallikarjun Reddy Ravi is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of chemistry, particularly in the area of pharmaceutical compounds. His work focuses on the development of methods that enhance the efficiency of chemical processes.
Latest Patents
Mallikarjun holds a patent for a conversion process for 2,3-benzodiazepine enantiomers. This patent describes methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer. This innovative approach has the potential to impact the pharmaceutical industry significantly.
Career Highlights
Mallikarjun is currently associated with Vela Acquisition Corporation, where he applies his expertise in chemical processes. His work at the company showcases his commitment to advancing scientific knowledge and practical applications in the field.
Collaborations
Some of his notable coworkers include Yong Victoria Wei and Naidaong Ye. Their collaborative efforts contribute to the innovative environment at Vela Acquisition Corporation.
Conclusion
Mallikarjun Reddy Ravi's contributions to the field of chemistry and his innovative patent demonstrate his dedication to advancing pharmaceutical science. His work continues to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile